NEWS 2/2011
FTIR measuring technology – untreated and recycled polymers compared IRAffinity-1 Raw materials are becoming increasingly scarce and more expensive. In its IP/11/122 press release entitled “The Commission calls for action…
Category: Application
Markets: Chemical, Petrochemical, Biofuel and Energy | Environment
NEWS 2/2011
…sample preparation. In this example, a building site measuring 30 m x 30 m is examined for contamination by heavy metals. The task is perfectly suited for the EDX-720, Shimadzu’s…
Category: Application
Markets: Environment
NEWS 1/2011 β Pharma Special
…in all substances and materials in a pharmaceutical product. For example, toxic heavy metals such as cadmium (Cd), mercury (Hg) and lead (Pb) are checked normally. It is also common…
Category: Chemistry/Manufacturing/Control
Markets: Pharmaceutical
NEWS 1/2011 β Pharma Special
…the complete plant needs to be dismantled and all components cleaned individually. This procedure requires more time and staff resources. Due to the individual cleaning, standardization and validation is more…
Category: Chemistry/Manufacturing/Control
Markets: Pharmaceutical
NEWS 1/2011 β Pharma Special
…guidelines were measured as residual metal catalysts in the pharmaceutical substances. Reagents commercially available for research purposes were used as the samples. For convenience in these tests, an organic solvent…
Category: Chemistry/Manufacturing/Control
Markets: Pharmaceutical
NEWS 1/2011 β Pharma Special
…operating costs (www.wako-chemicals.de). Table 1: Reproducibility of retention time of the different amino acids in comparison to 1/7/15 days New software significantly improves data analysis In addition, the newly developed…
Category: Chemistry/Manufacturing/Control
Markets: Pharmaceutical
NEWS 1/2011 β Pharma Special
…on their compact dimensions and straightforward exchange of load cells and accessories, testing machines in the EZ-Test model series are particularly versatile and convenient. A distinct feature is the comprehensive…
Category: Chemistry/Manufacturing/Control
Markets: Pharmaceutical
NEWS 1/2011 β Pharma Special
…significantly increases the requirements with which a pharmaceutical company must comply in order to demonstrate that all drug products (not just new) are compliant with Chapter <467> limits. The change…
Category: Drug Testing
Markets: Pharmaceutical
NEWS 1/2011 β Pharma Special
…with the strong eluent: MeOH or ACN. The following example of an optimization of a separation of sulfonamides and additional drugs underlines the power of the DryLab2010 and Nexera combination….
Category: Method Development
Markets: Pharmaceutical
NEWS 1/2011 β Pharma Special
…needed which will select the requested comparison analysis based on Pharmacopoeia. A comparison can be: a simple visual comparison search in a library purity check comparison of dedicated signals contaminant…
Category: Drug Optimization
Markets: Pharmaceutical